Short and long term results of percutaneous transhepatic cholangioscopic lithotomy in the treatment of intrahepatic duct stones
10.3760/cma.j.issn.1007-631X.2016.03.010
- VernacularTitle:经皮肝穿刺胆管造瘘电子胆道镜取石术治疗肝内胆管结石的近远期疗效
- Author:
Shu XU
;
Jianquan ZHANG
;
Guozhen FU
;
Ming LYU
;
Shuai ZHOU
- Publication Type:Journal Article
- Keywords:
Cholelithiasis;
Laparoscopes;
Percutaneous hepatocholangiostomy
- From:
Chinese Journal of General Surgery
2016;31(3):212-214
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the short and long term curative effects of percutaneous transhepatic cholangioscopic lithotomy (PTCSL) in the treatment of intrahepatic stone (IHS).Methods 38 IHS patients were enrolled,who were treated with PTCSL between January 2008 and July 2013.Results PTCSL was successfully completed in all the 38 IHS cases.Stone clearance rate was 84.2％ and the average episode of stone removal was (2.6 ± 0.9) times.Average diameter of percutaneous transhepatic fistula was (18.4 ± 0.6) F and the average time from percutaneous transhepatic puncture and fistulization to cholangioscopic lithotomy was (7.2 ± 0.7)d.The average operation time was (68 ± 20) min,intraoperative blood loss was (20 ± 13) ml,and hospitalization was (4 ± 2) days.The hepatolith recurrence rate in patients with stones completely removed was 37.5％ (12/32),and 1 case developed into biliary cirrhosis.Patients with calculi residual suffered from higher hepatolith recurrence rate of 83.8％ (5/6),with biliary cirrhosis found in 1 case.Conclusions PTCSL is safe and effective in treating primary IHS,which is indicated in multiple recurrent IHS especially in after biliary surgery patients.It has the advantages of minimally invasion,less bleeding,less postoperative pain,less complications,and fast postoperative recovery.
